We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Morphic Holding Inc
5 own
4 watching
Current Price
$0
$1.75
(3.04%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
2,282.95M
52-Week High
60.23
52-Week Low
19.23
Average Volume
0.44M
Dividend Yield
--
P/E Ratio
--
Market Capitalization2,282.95M52-Week High60.2352-Week Low19.23Average Volume0.44MDividend Yield--P/E Ratio--What does the Morphic Holding Inc do?
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical trial for the treatment of inflammatory bowel disease; and preclinical trial to treat idiopathic pulmonary fibrosis and fibrosis diseases. The company is also developing avß6 for the treatment of fibrotic diseases, and avß8 to treat solid tumors, as well as various other products. Morphic Holding, Inc. has a research collaboration with Engitix Ltd for the identification of Morphic integrin technology amenable targets in fibrostenotic IBD; a collaboration agreement with Schrödinger, LLC for integrin targets; and a license agreement with Children s Medical Center Corporation to develop and commercialize products worldwide for any therapeutic or diagnostic use in humans and veterinary applications. It also has collaboration agreements with AbbVie Biotechnology Ltd and Janssen Pharmaceuticals, Inc. to discover or develop integrin-based therapeutics. Morphic Holding, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Read More
How much money does Morphic Holding Inc make?
News & Events about Morphic Holding Inc.
Globe Newswire
1month ago
WALTHAM, Mass., May 05, 2023 (GLOBE NEWSWIRE) -- Morphic Holding, Inc. (Morphic), a biopharmaceutical company developing a portfolio of oral integrin therapies for the treatment of serious chronic diseases, today announced the closing of an underwritten public offering of 6,133,334 shares of its ...
Globe Newswire
1month ago
WALTHAM, Mass., May 03, 2023 (GLOBE NEWSWIRE) -- Morphic Holding, Inc. (Nasdaq: MORF), a biopharmaceutical company developing a portfolio of oral integrin therapies for the treatment of serious chronic diseases, today announced the pricing of an underwritten public offering of 5,333,334 shares of ...
Ticker Report
1month ago
Morphic Holding, Inc. (NASDAQ:MORF Get Rating) President Bruce Rogers sold 10,000 shares of Morphic stock in a transaction on Monday, April 17th. The shares were sold at an average price of $40.35, for a total transaction of $403,500.00. Following the completion of the sale, the president ...
InvestorPlace
1month ago
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
If you can handle the risks associated with high volatility, these biotech stocks to buy might double the returns in your portfolio.
The post 7 Biotech Stocks to Buy for 100% Returns appeared first on InvestorPlace...
Globe Newswire
3 months ago
WALTHAM, Mass., March 03, 2023 (GLOBE NEWSWIRE) -- Morphic Therapeutic(Nasdaq: MORF), a biotechnology company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced that its management team will participate a panel discussion focused on ...
Frequently Asked Questions
Frequently Asked Questions
What is Morphic Holding Inc share price today?
Can Indians buy Morphic Holding Inc shares?
How can I buy Morphic Holding Inc shares from India?
Can Fractional shares of Morphic Holding Inc be purchased?
What are the documents required to start investing in Morphic Holding Inc stocks?
What is today’s traded volume of Morphic Holding Inc?
What is today’s market capitalisation of Morphic Holding Inc?
What is the 52-Week High and Low Range of Morphic Holding Inc?
What percentage is Morphic Holding Inc down from its 52-Week High?
What percentage is Morphic Holding Inc up from its 52-Week Low?
Current Price
$0
$1.75
(3.04%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.